Dianthus Therapeutics, Inc.

🚨 Hot Jobs Alert! 🚨 We are #hiring! The Director, MSAT will play a pivotal role in the development, scale-up, and optimization of antibody manufacturing processes, ensuring the highest standards of quality, efficiency, and regulatory compliance. The individual in this role will be responsible for overseeing upstream and downstream process development for biologics drug substance production. They will also lead drug substance manufacturing, manage and troubleshoot all production releases, PPQ, and work alongside internal and external partners. Learn more about this role here: https://lnkd.in/giujRkmR Tom Chen #Hiring #JobOpportunites #Biotech #Biotechnology #Innovation

✨ #TalentTuesday ✨ Each member of #TeamDianthus is motivated by the potential to improve the lives of patients. Read Gary O'Donnell's take on what inspires him each day! #GrowWithUs #Biotech

Dianthus is growing! If you are interested in joining a team dedicated to developing the next generation of complement therapeutics to treat severe autoimmune diseases, check out our open positions. We’re always on the lookout for people who are passionate about science and healthcare to join #TeamDianthus: https://lnkd.in/gzePj2Xp #Hiring #Biotech #Innovation #Biotechnology

✨#TalentTuesday ✨ At Dianthus, a strong team dynamic is the backbone of our success. Members of #TeamDianthus help us build a supportive and motivating culture, allowing us to further unlock the capabilities of complement therapeutics to help patients. Meet Danielle, a Senior Clinical Trial Associate who is passionate about creating an encouraging and empowering team environment. #GrowWithUs #Biotech

This National Women’s History Month, we commend women whose scientific achievements had a significant impact on the biotech industry we work in today. At Dianthus, we are proud to support women who are shaping the future of science. Today, we celebrate Professor Brigitte Askonas, who was credited with co-developing one of the first systems for the cloning of antibody-forming B cells in vivo, generating some of the earliest monoclonal antibodies. #WomenInStem #WomenInScience #WomensHistoryMonth #Biotech #Biotechnology #Innovation

In honor of National Women’s History Month, we celebrate the incredible achievements of female scientists whose contributions have helped build the foundations of numerous medicines. We are proud to continue the legacy of these powerful women by striving to deliver treatments to patients with unmet needs.   Professor Margaret Dayhoff was a crucial figure in the field of biotech. Dayhoff is celebrated as the founder of bioinformatics, and her early contributions toward scientific research paved the way for today’s innovations.   #WomenInStem #WomenInScience #WomensHistoryMonth #Biotech #Biotechnology #Innovation

As we honor National Women’s History Month, we proudly recognize the large-scale contributions of women in science. This month, we will highlight three talented women whose previous contributions continue to inspire new generations today. Today, we honor Gertrude Elion, a recipient of the 1988 Nobel Prize in Physiology or Medicine. Elion is recognized for her research, which transformed the methodology of the development of new drugs. #WomenInStem #WomenInScience #WomensHistoryMonth #Biotech #Biotechnology #Innovation

Today we announced Q4 and FY 2024 financial results. We remain on track with each of our three ongoing clinical trials for DNTH103 in generalized Myasthenia Gravis (gMG), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Multifocal Motor Neuropathy (MMN). Read more about our results and progress: https://lnkd.in/geANDhyF #Biotech #Innovation #Biotechnology

We are excited to introduce our new Chief Commercial Officer, John King! John brings over 25 years of global commercial leadership experience in the biotechnology sector, including the launch of the first approved biologic and C5 complement inhibitor into the Myasthenia Gravis market and leading the commercial strategy behind the first FDA-approved, self-administered, subcutaneous biologic for gMG. Please join us in extending a warm welcome to John! #Biotech #Biotechnology #Innovation

Autoimmune diseases often have similar and overlapping symptoms, leaving many patients still searching for a diagnosis. This month, we encourage everyone to learn more about the different conditions and patient experiences by following the hashtag #AutoimmuneAwarenessMonth and updates from the Autoimmune Association.